Seclazone

This classification denotes a uricosuric agent with the molecular formula C10H8ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JW3UZ4I1A8, chemically known as 3,3a-dihydro-7-chloro-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one but generally known as seclazone, which bears US NIH Compound Identifier 34443. European Medicines Agency schedules Seclazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10466MIG. The term SECLAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). SECLAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule seclazone under HS 29349990 and SITC 51579. As of Q4 2014, SECLAZONE remains the US FDA Preferred Term for this commodity. Seclazone bears US NLM identifiers UMLS ID C0644512 and NCI Concept Code C73105. SMILES: C1CON2C1OC3=C(C2=O)C=C(C=C3)CL.